Tirzepatide, a dual GIP/GLP-1 receptor agonist, attenuates endothelial dysfunction and angiotensin II-induced abdominal aortic aneurysm in ApoE(-/-) mice.
- DOI
- 10.1016/j.phrs.2026.108321
- Published
- 2026 Aug
- Container
- Pharmacological research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.phrs.2026.108321,
title = {Tirzepatide, a dual GIP/GLP-1 receptor agonist, attenuates endothelial dysfunction and angiotensin II-induced abdominal aortic aneurysm in ApoE(-/-) mice.},
author = {Gómez-Martín Á and Marques P and Arce-Recatalá C and Vea Á and Domingo E and Alabadi B and Real JT and Sanz MJ and Piqueras L},
year = {2026},
journal = {Pharmacological research},
doi = {10.1016/j.phrs.2026.108321},
url = {https://doi.org/10.1016/j.phrs.2026.108321}
}RIS
TY - JOUR TI - Tirzepatide, a dual GIP/GLP-1 receptor agonist, attenuates endothelial dysfunction and angiotensin II-induced abdominal aortic aneurysm in ApoE(-/-) mice. AU - Gómez-Martín Á AU - Marques P AU - Arce-Recatalá C AU - Vea Á AU - Domingo E AU - Alabadi B AU - Real JT AU - Sanz MJ AU - Piqueras L PY - 2026 JO - Pharmacological research DO - 10.1016/j.phrs.2026.108321 UR - https://doi.org/10.1016/j.phrs.2026.108321 ER -
APA
Á, G., P, M., C, A., Á, V., E, D., B, A., JT, R., MJ, S., & L, P. (2026). Tirzepatide, a dual GIP/GLP-1 receptor agonist, attenuates endothelial dysfunction and angiotensin II-induced abdominal aortic aneurysm in ApoE(-/-) mice.. Pharmacological research. https://doi.org/10.1016/j.phrs.2026.108321
Source records
- pubmed · retrieved 2026-09-26T14:10:53.042Z